Clinical Trial Update: Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating escitalopram for obsessive-compulsive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Obsessive Compulsive Disorder | Phase 4 | Status: COMPLETED